1
News
Extremadura, a pioneer in launching a Profit Sharing program for the use of biosimilar medicines in the SES
On February 27, Extremadura became the first Autonomous Community to launch a Profit Sharing Program for the use of biosimilar medicines. This pioneering initiative in the national territory stems from an agreement between the Junta de Extremadura and BioSim that aims to promote an efficient prescription of biological drugs with biosimilars and link part of the savings generated to the health system itself to improve, for example, access to drugs innovative. Collaboration between management professionals and healthcare professionals responsible for prescribing and caring for patients, as well as determining what information is to be provided to patients, are key aspects of the success of profit programs shared.
Extremadura joint
https://www.juntaex.es/w/convenio-sanidad
2
Infographics
Infographic series on international profit sharing experiences
In this series of infographics produced by BioSim, four cases of international gainsharing experiences in European countries are reviewed. Whether at the national, regional or local level, these countries have been pioneers in using profit-sharing models to promote the use of biosimilar medicines. In the case of France, a national instruction links the prescription of biosimilars of three active ingredients to an incentive for the hospital; Italy, for its part, in the Campania region allowed reinvesting savings derived from the use of biosimilars in the acquisition of innovative drugs. In the case of England and Ireland, gainsharing models have been widely used at the hospital level to promote the use of biosimilar drugs, especially anti-TNFs.
biosim
https://www.biosim.es/infografias-sobre-medicamentos-biosimilares/
- https://www.biosim.es/experiencias-internacionales-de-ganancias-compartidas-para-el-fomento-de-los-medicamentos-biosimilares-irlanda/
- https://www.biosim.es/experiencias-internacionales-de-ganancias-compartidas-para-el-fomento-de-los-medicamentos-biosimilares-francia/
- https://www.biosim.es/experiencias-internacionales-de-ganancias-compartidas-para-el-fomento-de-los-medicamentos-biosimilares-italia/
- https://www.biosim.es/experiencias-internacionales-de-ganancias-compartidas-para-el-fomento-de-los-medicamentos-biosimilares-reino-unido/
3
Report
Basis for a biosimilar gainsharing project
This document, coordinated by the specialized medical consultant Ignacio Riesgo and enriched with the contributions of a multidisciplinary group of health professionals, aims to lay the general foundations for a gainsharing plan in biosimilars, fundamentally using the switch. The final objective is to serve as a general framework, which must necessarily be adapted to the specific circumstances of each Service/Clinical Unit, for the start-up of one or several profit-sharing pilots in relation to biosimilars.
biosim
4
Webinar
Gainsharing and Biosimilars: From Theory to Practice
The National Health Service defines a profit-sharing agreement as “one where the benefits associated with the more efficient use of medicines are shared between the parties involved: the health provider (hospital) and the payer”. Several European countries have launched profit-sharing programs to optimize spending on biological medicines, demonstrating that this type of agreement can generate benefits for both patients, health professionals or the Health System itself. Is it possible to implement this type of program in the National Health System? This is one of the questions that an attempt was made to answer in this webinar, in which the results of international experiences were briefly reviewed, a proposal for the general bases for implementing these agreements was presented, and how these programs can be translated into innovative management initiatives in the hospital environment.
biosim
https://www.youtube.com/watch?v=a4uEf3Mog-w
5
Infographic
KEYPOINTS Profit Sharing Agreements
This infographic, the result of the session for health managers organized by the Consorci de Salut i Social de Catalunya and BioSim and held on March 15, 2022, includes the key points of profit sharing agreements. It includes everything from the definition of this particular type of incentive to the areas in which it can be applied, including the elements required to put this model into practice in the area of health management.
Health and Social Consortium of Catalonia and BioSim
https://www.biosim.es/documentos/ganancias-compartidas-15M-infografiaV2.pdf